For the nine months ended 30 September 2020, BayerAG revenues decreased 4% to EUR31.41B. Net loss beforeextraordinary items totaled EUR15.95B vs. income ofEUR2.43B. Revenues reflect Pharmaceuticals - Ultravistsegment decrease of 16% to EUR144M, Pharmaceuticals -Xofigo segment decrease of 18% to EUR62M. Net loss reflectsOther operating expenses increase from EUR1.54B toEUR16.63B (expense).
Show more
Income Statement
Total RevenueNet Income
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
8506
10054
12845
10750
1711
6036
8189
5875
-9399
-10784
2499
396
-2744
-9548
1489
1414
Period Ending:
Total Revenue
Gross Profit
Operating Income
Net Income
Gross marginTTM60.23%
Operating marginTTM-15.35%
Net Profit marginTTM-16.71%
Return on InvestmentTTM-7.66%
Balance Sheet
Total AssetsTotal Liabilities
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
119520
123667
125474
126174
88193
87963
76865
78921
31327
35704
48609
47253
Period Ending:
Total Assets
Total Liabilities
Total Equity
Quick RatioMRQ0.62
Current RatioMRQ0.9
LT Debt to EquityMRQ95.08%
Total Debt to EquityMRQ115.73%
Cash Flow
CashNet Change in Cash
Sep 30, 2020 9 Months
Jun 30, 2020 6 Months
Mar 31, 2020 3 Months
Dec 31, 2019 12 Months
4145
2178
-236
8187
-3879
-1019
-598
-671
1777
-1090
36
-8389
1882
-30
-866
-867
Period Ending:
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
Cash Flow/ShareTTM-2.92
Revenue/ShareTTM44.29
Operating Cash Flow11.58%
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Get free real time quotes, charts and alerts on stocks, indices, currencies, commodities and bonds.
Get free top of the line technical analysis/predictors.
Investing.com is better on the App!
More content, faster quotes and charts, and a smoother experience is available only on the App.